TABLE 2.
Variable | Characteristic for:
|
||||
---|---|---|---|---|---|
Griseofulvin | Ketoconazole | Itraconazole | Fluconazole | Terbinafine | |
Systemic administration | Oral | Oral | Oral | Oral or intravenous | Oral |
Related concerns or problems | Tolerance, treatment length | Toxicity, interactions | Interactions | Interactions, Candida resistance | Adverse events |
Affinity for keratin | Low | High | High | High | High |
Excretion in sweat | High | High | Minimal | High | None |
Excretion in sebum | Limited | Limited | High | Limited | High |
Drug concnb | P = S | P = S | S > P | S > P | P = S |
Time to reach stratum corneum | Epidermis within 8 h | Unknown | Within 24 h | Within 24 h | Within 8 h |
Appropriate for skin | Yes | Yes | Yes | Yes | Yes |
Appropriate for onychomycosis | No | No | Yes | Yes | Yes |
Adapted from reference 7 with permission of the publisher.
P, plasma; S, skin.